Resistance to lamivudine therapy: is there more than meets the eye?
- PMID: 15591497
- PMCID: PMC1774354
- DOI: 10.1136/gut.2004.047548
Resistance to lamivudine therapy: is there more than meets the eye?
Comment on
-
High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.Gut. 2005 Jan;54(1):152-61. doi: 10.1136/gut.2003.032920. Gut. 2005. PMID: 15591521 Free PMC article.
References
-
- Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001;34:617–24. - PubMed
-
- Dusheiko GM. Interferon alpha: Biology, pharmacology and therapy for chronic viral hepatitis. In: Thomson AW, Lotze MT, eds. The cytokine handbook. London: Elsevier Science, 2003:1233–54.
-
- Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000–Summary of a workshop. Gastroenterology 2001;120:1828–53. - PubMed
-
- Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004;2:87–106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources